Thanks for the link, Marker2. Phylogica is in that exciting space for investors where tremendous potential built upon the back of an innovative science is ready to be unlocked. The commercialization process began with the Roche agreement. Dr Wilson states in the webcast that;
"[Phylogica] is currently progressing in parallel multiple deal opportunities with major pharmaceutical companies, a number of these are at the research plan stage, others at the term sheet stage and one of the major ones is already at the stage of finalising the contract."
Deal delivery will translate into a higher share price as Phylogica builts a market capitalisation of at least $200m over the next 24 months (refer company presentations). Wilson, Watt and Woolf represents a formidable and experienced team to turn a good idea into a powerhouse drug discovery company - the lineup of big pharma at the door to sign licencing agreements is the best possible evidence that PYC is the Real Deal.
PYC Price at posting:
8.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)